Your English writing platform
Discover LudwigSuggestions(1)
Exact(3)
Additionally, time from documented first organ dysfunction to start of study drug administration was shorter for third and subsequent patients enrolled at a site compared with the first two patients enrolled.
Following extensive exploratory analysis, we identified that a six hour cutoff increment appeared to make a difference in terms of survival, and so the variable for time from first sepsis-induced organ dysfunction to start of study drug was divided by six in order to determine if there were differences in outcome by six-hour intervals from onset of organ dysfunction to treatment.
Twenty-eight-day mortality was compared between patients who received early treatment (defined as less than 24 hours from first sepsis-induced organ dysfunction to start of infusion of DrotAA) and those who received late treatment (24 hours or more to start of infusion of DrotAA).
Similar(57)
Plenty of dysfunction to go around.
But it says here that when your organization was among the World Series favorites, and then stumbled through a nightmare campaign capped off by a dugout fight involving your most important player, the dismissal of your manager, and a brutal series of reports about clubhouse dysfunction, it might be nice to start over with a clean and neat hiring.
The time from the first organ dysfunction to the start of DrotAA treatment differed between those with and without PF, MEN, or MD.
Less time elapsed from first organ dysfunction to the start of DrotAA treatment in patients with PF, MEN, or MD (mean 18.3 hours) than in those without (mean 22.6 hours).
Although ENHANCE potentially allowed a longer window than PROWESS from first organ dysfunction to the start of treatment, the median time-to-DroAA treatment for patients with PF, MEN, or MD from ENHANCE was 15.7 hours; for those treated with DroAA from PROWESS it was 18.6 hours.
The research available focus on the right time to start therapy, but only evaluating renal dysfunction characteristics.
The initial decline in cognition was postulated to occur already during stages 3 and 4 i.e. around the same time when the initial manifestation of somatosensor dysfunction start to appear.
The autosomal dominant nonsyndromic hearing disorder DFNA9 is characterized by late onset bilateral progressive high-frequency sensorineural hearing impairment with associated variable vestibular dysfunction and starts to manifest between 20 and 50 years of age [ 24].
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com